Supplemental material
OncoImmunology
Volume 7, 2018 - Issue 8
Original Research
Lymphatic vessel density is associated with CD8+ T cell infiltration and immunosuppressive factors in human melanoma
Natacha BordryClinical Tumor Biology and Immunotherapy Group, Department of Oncology and Ludwig Cancer Research, University of Lausanne (UNIL), Lausanne, Switzerland;Institute of Bioengineering and Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
http://orcid.org/0000-0002-3523-438XView further author information
http://orcid.org/0000-0002-3523-438XView further author information, Maria A. S. BroggiInstitute of Bioengineering and Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland;Institute for Molecular Engineering, University of Chicago, Chicago, IL, USAhttp://orcid.org/0000-0001-7909-5097View further author information
http://orcid.org/0000-0001-7909-5097View further author information, Kaat de JongeClinical Tumor Biology and Immunotherapy Group, Department of Oncology and Ludwig Cancer Research, University of Lausanne (UNIL), Lausanne, Switzerlandhttp://orcid.org/0000-0003-2306-5555View further author information
http://orcid.org/0000-0003-2306-5555View further author information, , , , , , , Manuel FankhauserInstitute of Bioengineering and Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerlandhttp://orcid.org/0000-0001-7714-6524View further author information
http://orcid.org/0000-0001-7714-6524View further author information, , , Samia Abed-MaillardDepartment of Oncology, Lausanne University Hospital Center (CHUV) and University of Lausanne, Lausanne, Switzerlandhttp://orcid.org/0000-0003-4773-8072View further author information
http://orcid.org/0000-0003-4773-8072View further author information, Hélène Maby-El HajjamiClinical Tumor Biology and Immunotherapy Group, Department of Oncology and Ludwig Cancer Research, University of Lausanne (UNIL), Lausanne, Switzerlandhttp://orcid.org/0000-0002-5786-5991View further author information
http://orcid.org/0000-0002-5786-5991View further author information, , Kalliopi IoannidouClinical Tumor Biology and Immunotherapy Group, Department of Oncology and Ludwig Cancer Research, University of Lausanne (UNIL), Lausanne, Switzerlandhttp://orcid.org/0000-0001-9097-4199View further author information
http://orcid.org/0000-0001-9097-4199View further author information, Igor LetovanecDepartment of Pathology, CHUV, Lausanne, Switzerlandhttp://orcid.org/0000-0002-0410-3491View further author information
http://orcid.org/0000-0002-0410-3491View further author information, , , Maurice MatterDepartment of Oncology, Lausanne University Hospital Center (CHUV) and University of Lausanne, Lausanne, Switzerland;Department of Surgery, CHUV, Lausanne, Switzerlandhttp://orcid.org/0000-0003-1816-3003View further author information
http://orcid.org/0000-0003-1816-3003View further author information, & Daniel E. SpeiserClinical Tumor Biology and Immunotherapy Group, Department of Oncology and Ludwig Cancer Research, University of Lausanne (UNIL), Lausanne, Switzerland;Department of Oncology, Lausanne University Hospital Center (CHUV) and University of Lausanne, Lausanne, SwitzerlandCorrespondence[email protected]
http://orcid.org/0000-0003-2031-3250View further author information
http://orcid.org/0000-0003-2031-3250View further author information show all